MedPath

Eating Disorders Programs: An Indicated Trial

Not Applicable
Completed
Conditions
Body Image
Eating Disorders
Registration Number
NCT03259347
Lead Sponsor
Oregon Research Institute
Brief Summary

The purpose of this study is to assess the effectiveness of two body acceptance programs for women. Participants may experience reduction of eating pathology and prevention of future obesity and eating disorders; may derive a sense of altruism and contribution to furthering understanding of a public health problem.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
534
Inclusion Criteria
  • Participant indicates sub-threshold or threshold eating disorder.
  • Participant is available to participate in the intervention sessions.
  • Participants must be MRI eligible.
Exclusion Criteria
  • Participant does not indicate sub-threshold or threshold eating disorder.
  • Participant is unable to attend intervention sessions.
  • Participant cannot participate if MRI ineligible.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change from Baseline Eating Disorder Diagnostic responses using the Eating Disorder Examination questionnaire at 8 weeks and 6 monthsMeasured at baseline, week 8, and Month 6

Evaluate change (if any) by using the Eating Disorder Examination questionnaire at the 8 week and 6 month mark.

Secondary Outcome Measures
NameTimeMethod
Assessments using Beliefs About Appearance ScaleMeasured at baseline, week 8, and Month 6

Evaluate participants' perceptions and beliefs on physical appearance.

Assessments using Ideal-Body Stereotype Scale-RevisedMeasured at baseline, week 8, and Month 6

Evaluate the participants' perception of the ideal-body stereotype

Assessments using Dutch Restrained Eating ScaleMeasured at baseline, week 8, and Month 6

Evaluate participants ability to exercise restraint in regards to food

Assessments using Positive Affect and Negative Affect Scale-RevisedMeasured at baseline, week 8, and Month 6

Measure participants' affect and monitor any changes that may occur.

Assessments using Satisfaction and Dissatisfaction with Body Parts ScaleMeasured at baseline, week 8, and Month 6

Evaluate participants' level of satisfaction and dissatisfaction with specific parts of their bodies

Trial Locations

Locations (3)

Oregon Research Institute

🇺🇸

Eugene, Oregon, United States

Drexel University

🇺🇸

Philadelphia, Pennsylvania, United States

The University of Texas

🇺🇸

Austin, Texas, United States

Oregon Research Institute
🇺🇸Eugene, Oregon, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.